The results of the Clopidogrel Medco Outcomes Study, [8] presented at The Society for Cardiovascular Angiography and Interventions (SCAI) meeting in May 2009, prompted the SCAI to issue a ...

Ray and colleagues' retrospective cohort study used automated access to data to evaluate patients who had received clopidogrel during a focused analysis from 1999 to 2005 in a Tennessee Medicaid ...

Please provide your email address to receive an email when new articles are posted on . Concomitant proton pump inhibitor plus ticagrelor monotherapy after PCI does not increase risk for all-cause ...

An appropriate duration of dual antiplatelet therapy after percutaneous coronary intervention for acute myocardial infarction that has been treated with guideline-recommended complete ...

Earlier this year, two retrospective studies linked the combined use of proton-pump inhibitors (PPIs) and clopidogrel (Plavix) with increased adverse cardiovascular events in patients who had acute ...

There was no benefit to modulating the intensity of antiplatelet therapy compared with standard antiplatelet therapy in high-risk patients who had undergone complex stenting procedures, according to ...

NEW ORLEANS, LA—Among patients with atrial fibrillation (AF) undergoing PCI, 1 month of dual therapy with a direct oral ...

Dual antiplatelet therapy after heart bypass surgery is not more effective than aspirin alone - and it increases the risk of excessive bleeding. This has now been shown in a study of 2,201 patients at ...

Dual antiplatelet therapy after cardiac bypass surgery is no more effective than acetylsalicylic acid alone and also increases the risk of serious bleeding. This is shown in a study by researchers at ...